Deloitte 2025 Life Sciences Outlook Report Finds Medtech Leaders Focus On AI, GenAI Adoption Across Value Chain To Increase Efficiencies, Cut Costs

The Deloitte 2025 Life Sciences Outlook report highlights cautious optimism among life sciences and medtech executives, with 75% expressing confidence in revenue growth despite challenges. AI and digital transformation are central to their strategies, enabling cost savings and operational efficiencies. Medtech Insight also spoke with Deloitte’s US Consulting Medtech Practice Leader, Sheryl Jacobson, about her medtech outlook for 2025.